control embryos. However, analysis of neutral lipids by TLC showed that MBCD microinjection increased the fatty-acid content, while decreasing triacylglycerol levels. doi:10.1016/j.ydbio.2009.05.143 Program/Abstract # 123 Expression pattern of genes related to lipid rafts formation during Xenopus laevis development Amado G. Nathália, Débora M. Cerqueira, José G. Abreu Instituto de Ciências Biomédicas, UFRJ, Rio de Janeiro, RJ, Brazil Lipid rafts are membrane microdomains (MM) with high content of cholesterol and sphingolipids. It has been shown that these structures play a role in intracellular trafficking and can act as platforms for signaling complex. We showed recently that cholesterol depletion within plasma membrane disrupted MM assembly, affecting anterior development of Xenopus embryos, correlating MM and head formation. Two genes previously identified and involved with cholesterol biosynthesis (Xen1) and organization of lipid rafts (Xen2) are here investigated. Since cholesterol and MM seems to play a role during Xenopus development, we decided to investigate the expression pattern of these genes during embryonic development of Xenopus laevis. The cDNAs containing ESTs of these genes were obtained at gene database. These sequences showed high degree of identity with human, zebra-fish, rat and mouse, and are therefore possible candidates for orthologues in Xenopus. In situ hybridization was performed in different stages of development and showed that these genes are expressed at the animal pole, branchial arches, optical vesicles, olfactory placodes, pronephric area and neural plate. At tailbud and tadpole stages, expression is detected at the dorsal region, along the anteroposterior axis and somites. At neurula stage Xen2 expression was restricted in neural crest tissue. RT-PCR analysis showed that both genes are expressed at early and latter stages. These results showed that Xen1 and 2 are expressed at specific areas and stages, suggesting that these orthologues can play a significant role during Xenopus development. has not yet been rigorously defined nor has the requirement for Wnt6. As a first step toward understanding the signaling pathway utilized by Wnt6, I tested Wnt6 activity in COS7 cells. I found that Wnt6 inhibits β-catenin dependent Wnt signaling, suggesting that Wnt6 acts through a β-catenin independent pathway in COS7 cells. As the signaling pathways used by Wnts are tissue dependent, I am now extending these studies into somites. To further investigate the role (s) of Wnt6 in somite patterning, I have examined the phenotypes of somites in embryos transfected with overexpression constructs for Wnt6. Interestingly, overexpression of Wnt6 causes an expansion in the size of the dermomyotome without affecting the size of the myotome. To test the requirement of Wnt6, I first generated a detailed map of the Wnt6 expression pattern using in situ hybridization. Wnt6 transcripts are expressed in the ectoderm overlying the segmental plate, epithelial somites, intermediate mesoderm, and lateral plate mesoderm. As the somites compartmentalize, Wnt6 expression decreases and becomes restricted to the ectoderm overlying the lateral plate mesoderm and neural tube. With this information, I am currently knocking down Wnt6 expression using shRNA and analyzing the effects on the epithelial dermomyotome. The current model of somitogenesis postulates a Wavefront signal in the posterior of the embryo and that maintains the undifferentiated state of the presomitic mesoderm (PSM). Previous work in cultured embryos suggests that FGF activity is the Wavefront signal. However, it is unclear which (if any) of the six FGFs expressed in the PSM encode this activity, as our work and others' has shown that removal of any one ligand is insufficient to disrupt early somitogenesis. Here we show that when both Fgf4 and Fgf8 are ablated in the PSM, only a few abnormal somites form and embryonic axis elongation stops at the 3-somite stage. Expression of most PSM genes is absent in mutants, including cycling genes, markers of undifferentiated PSM, and WNT genes. Significantly, somite markers are expanded into the PSM, suggesting that the loss of PSM markers is due to premature differentiation of the PSM into somitic tissue. Loss of WNT signaling also causes axis truncation, so we investigated whether the phenotype of the mutants was a secondary effect. When WNT signaling is restored by activation of a gain-of-function Bcatenin allele in the mutant PSM, undifferentiated PSM markers such as T are partially restored, but axis elongation and somite formation are not rescued. This study demonstrates that loss of FGF signaling results in premature differentiation of the PSM, and provides the first genetic evidence identifying FGF ligands (Fgf4 and Fgf8) that encode Wavefront activity. Furthermore, these data suggest that FGF action is required to maintain WNT signaling, and that both signaling pathways are required in parallel to maintain undifferentiated PSM tissue.
In vertebrate development, somites are patterned by extrinsic signals, including Wnts. We are particularly interested in determining the role of Wnt6, which is expressed in the ectoderm overlying developing somites. Researchers have demonstrated that Wnt6 is important in the formation or maintenance of epithelial somite structures. Yet, the pathway used by Wnt6 in somite patterning has not yet been rigorously defined nor has the requirement for Wnt6. As a first step toward understanding the signaling pathway utilized by Wnt6, I tested Wnt6 activity in COS7 cells. I found that Wnt6 inhibits β-catenin dependent Wnt signaling, suggesting that Wnt6 acts through a β-catenin independent pathway in COS7 cells. As the signaling pathways used by Wnts are tissue dependent, I am now extending these studies into somites. To further investigate the role (s) of Wnt6 in somite patterning, I have examined the phenotypes of somites in embryos transfected with overexpression constructs for Wnt6. Interestingly, overexpression of Wnt6 causes an expansion in the size of the dermomyotome without affecting the size of the myotome. To test the requirement of Wnt6, I first generated a detailed map of the Wnt6 expression pattern using in situ hybridiza- The current model of somitogenesis postulates a Wavefront signal in the posterior of the embryo and that maintains the undifferentiated state of the presomitic mesoderm (PSM). Previous work in cultured embryos suggests that FGF activity is the Wavefront signal. However, it is unclear which (if any) of the six FGFs expressed in the PSM encode this activity, as our work and others' has shown that removal of any one ligand is insufficient to disrupt early somitogenesis. Here we show that when both Fgf4 and Fgf8 are ablated in the PSM, only a few abnormal somites form and embryonic axis elongation stops at the 3-somite stage. Expression of most PSM genes is absent in mutants, including cycling genes, markers of undifferentiated PSM, and WNT genes. Significantly, somite markers are expanded into the PSM, suggesting that the loss of PSM markers is due to premature differentiation of the PSM into somitic tissue. Loss of WNT signaling also causes axis truncation, so we investigated whether the phenotype of the mutants was a secondary effect. When WNT signaling is restored by activation of a gain-of-function Bcatenin allele in the mutant PSM, undifferentiated PSM markers such as T are partially restored, but axis elongation and somite formation are not rescued. This study demonstrates that loss of FGF signaling results in premature differentiation of the PSM, and provides the first genetic evidence identifying FGF ligands (Fgf4 and Fgf8) that encode Wavefront activity. Furthermore, these data suggest that FGF action is required to maintain WNT signaling, and that both signaling pathways are required in parallel to maintain undifferentiated PSM tissue. A number of genes that are required for normal morphogenesis of developing embryos, including Fgf8, have been shown to have isoformspecific functions. To date, these genes have been identified in isolated experiments and by fortuitous splicing events associated with gene targeting. We predicted that alternative splicing, the process by which a single gene can produce several functionally distinct isoforms, is a common event required for establishment of the normal body plan. In this work, we present a whole genome approach, using exon microarrays, to profile the variation in pre-mRNA splicing, transcription initiation, and polyadenylation site choice during early murine development. We show that variation in isoform expression is widespread, and affects many genes with known and predicted function during embryonic development. We use RT-PCR and in-situ hybridization to further validate and investigate spatial and temporal expression patterns of specific isoforms. We propose that alternative isoform expression is a common mechanism controlling the diversity of developmental process, and that techniques such as isoform-specific knockouts, should be utilized to truly dissect the complexity of developmental pathways. In eutherian mammals, the murine allantois forms the umbilical component of the placenta, forming a system of blood vessels that mediates exchange of nutrients, wastes, and gases between the fetus and its mother. We have recently shown that the allantoic bud is formed by the extraembryonic primitive streak (XPS). Then, as the bud grows, the XPS expands into the Allantoic Core Domain (ACD), a germinal center, which is essential for allantoic elongation to the chorion. Subsequently, the allantois extends as a finger-like projection towards the chorion, and then fuses with the chorion, where maternal resources are pooled. Failure of the allantois to properly form an ACD prevents elongation. This prevents fusion with the chorion, which subsequently leads to birth defects. Despite the importance of the allantois in fetal survival and development, little is known about how it is established. Here, we are examining, by protein localization, the presence of Fibroblast Growth Factor (FGF) family members in the ACD. Our results suggest that FGF8, which is known to establish gradients of differentiation, and its receptor, FGFR3, are localized to the XPS prior to formation of the ACD, and then briefly, within the ACD after the latter has been established. This suggests that FGF8 may play a critical role in the establishment of the allantois' stem cell reservoir. In eutherian mammals, the chorio-allantoic placenta provides a means for nutrient and waste exchange by vascularly connecting the fetus to its mother. The umbilical component of the placenta matures from the allantois. In the mouse conceptus, the allantoic bud emerges from the extraembryonic posterior primitive streak (XPS). Then, the XPS expands into the Allantoic Core Domain (ACD), a putative stem cell niche that extends from the proximal allantois into the allantoic midline. The ACD contributes extensively to the allantois, including the vasculature, and is required for subsequent elongation, thereby allowing the allantois to extend toward, and ultimately fuse with, the chorion. During elongation, the base of the allantois contains a population of cells that express fragilis, a pluripotency marker. The cells with high fragilis are believed to be specified to the primordial germ cell (PGC) lineage. However, the fate of the remaining cells with low fragilis remains unclear. Recently, we observed that during bud stages, Fragilis-positive cells are largely confined to the proximal allantois, but after ACD formation, the localization of these cells mirrors that of the ACD, extending from the allantoic base into the midline. In addition, a few allantoic cells co-localize Fragilis and Flk-1, indicating that these cells, like some ACD cells, contribute to the umbilical vasculature. These data suggest that the Fragilis population at the allantoic base serves as a dual stem cell niche in which one part contributes to the PGC population while the other part functions as the ACD and contributes to the allantois. The embryonic hindbrain is divided into repetitive rhombomeres. This is critical for patterning, differentiation and migration of neurons and neural crest to form nerves, circuits and to generate brainstem, cerebellum and cranial structures. While the intrinsic segmental patterns are well-identified, how upstream signals coordinate to govern this patterning is less clear. This study aims to unravel whether FGF plays a key role in chick hindbrain patterning. Analysis of FGF signaling components reveals the expression of two ligands, FGF3 and 19 in specific segments, whereas all FGF receptors and downstream effectors i.e., dpERK, Erm, etc., are distributed in dynamic and more-expanded patterns. Furthermore, FGF3 overlaps with the BMP-inhibitor follistatin, suggesting that FGF3 expression/ activity requires follistatin. A loss-of-function approach, by which follistatin activity is prevented, results in FGF3-inhibition, whereas ectopic follistatin enhances FGF3 levels, confirming that segmental BMP-inhibition by follistatin regulates FGF3. This FGF3-follistatin cross-talk is upstream of Krox20 and Kreisler, key genes crucial for rhombomere identities. At later stages, FGF3 and follistatin are upregulated in hindbrain boundaries and lost from rhombomeres. Their segmental downregulation is induced by boundary cell-derived signals. Together, our data reveals a novel antagonistic BMPFGF relationship required for establishing segmental FGF3 expression to drive hindbrain patterning, and elucidates a new role of hindbrain boundaries to switch-off these segmental genes later in development. Forebrain development has been intimately linked with the TGFb signaling pathway, and several mutations in TGFb pathway members cause holoprosencephaly (HPE). In humans, HPE occurs in 1 out of 250 pregnancies, usually resulting in spontaneous abortion. From an ENU mutagenesis screen, we identified two mouse mutants, beaker
